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Abstract: The anti-inflammatory effects of anthocyanins (ACNs) on vascular functions are discussed
controversially because of their low bioavailability. This study was performed to determine whether
microorganism (MO)-fermented ACNs influence vascular inflammation in vitro. Therefore, MO
growth media were supplemented with an ACN-rich grape/berry extract and growth responses
of Escherichia coli, E. faecalis and H. alvei, as well as ACN fermentation were observed. MO
supernatants were used for measuring the anti-inflammatory effect of MO-fermented ACNs in an
epithelial-endothelial co-culture transwell system. After basolateral enrichment (240 min), endothelial
cells were stimulated immediately or after 20 h with TNF-α. Afterwards, leukocyte adhesion,
expression of adhesion molecules and cytokine release were measured. Results indicate that E. coli,
E. faecalis and H. alvei utilized ACNs differentially concomitant with different anti-inflammatory
effects. Whereas E. coli utilized ACNs completely, no anti-inflammatory effects of fermented ACNs
were observed on activated endothelial cells. In contrast, ACN metabolites generated by E. faecalis and
H. alvei significantly attenuated low-grade stimulated leukocyte adhesion, the expression of adhesion
molecules E-selectin, VCAM-1 and ICAM-1 and cytokine secretion (IL-8 and IL-6), as well as NF-κB
mRNA expression with a more pronounced effect of E. faecalis than H. alvei. Thus, MO-fermented
ACNs have the potential to reduce inflammation.
Keywords: grapes and berries; anthocyanins; low-grade inflammation; fermentation; in vitro
co-culture model
1. Introduction
Consumption of fruit and vegetables has been associated with a reduced risk of
inflammation-associated diseases, such as atherosclerosis, obesity, diabetes and metabolic syndrome [1,2].
Most of these diseases have been associated with low-grade inflammation (LGI), which is characterized
by an enhanced circulation of cytokines (TNF-α, IL-6) and chemokines (IL-8), resulting in chronic
activation of the vascular epithelium and recruitment of mononuclear cells [3]. The activation of
endothelial cells during inflammatory processes is a well-known multistep process in which multiple
cell adhesion molecules are expressed in a time-dependent manner [4]. The cell adhesion molecule
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E-selectin allows the first contact between mononuclear cells and the vascular endothelium during
inflammation [5,6]. Thereafter, molecules of the immunoglobulin superfamily, mainly intercellular
cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), are responsible
for the firm adhesion and transmigration of the cells into the tissue. The movement of mononuclear
cells as a result of dysregulated cell adhesion molecule expression is a key process in the onset and
progression of endothelial dysfunction. Interestingly, it has been reported that VCAM-1 plays a major
role in the initiation of atherosclerosis [7]. Therefore, the development of strategies to influence this
multistep process and thus prevent inflammation-associated diseases is a great challenge.
Epidemiological observation studies and intervention trials have suggested that fruit or vegetable
consumption provides anti-inflammatory and anti-adhesive effects beneficial for vascular function [8–11].
Lingonberries were shown to prevent diet-induced obesity and low-grade inflammation in mouse
models [12], and a healthy diet with fresh fruits and vegetables was associated with a lower endothelial
dysfunction and LGI in humans [13]. Such effects of fruits, especially berries, have been mainly
attributed to the presence of polyphenols with anthocyanins (ACNs) and phenolic acids (PAs) as the
most abundant components [14]. The predominant ACNs identified in berries, especially in red grapes,
include the 3-O-monoglucosides and the 3-O-acylated monoglucosides of cyanidin, delphinidin,
petunidin, peonidin and malvidin. However, in recent years, there has been increasing evidence
that not only the parental ACNs were responsible for the health effects, but also their fermented
degradation products. Although ACNs can be directly absorbed in the intestine without prior chemical
modification [15], plasma levels of intact ACNs were found in nmol concentrations, indicating that
their bioavailability is extremely low [16,17]. Nevertheless, recently-published data suggest that
intense MO fermentation in the colon generates metabolites responsible for the anti-inflammatory
effects seen in vivo [18–20]. Gut MO populations could use ACNs or further metabolites as growth
substrates. Although evidence related to the effects of ACNs on gut microbiota is still scarce and
inconclusive, it has recently been shown that polyphenols are able to modulate the microbiota growth
kinetics [21–26].
Consequently, colonic catabolism of ACNs may play a major role in the production of new
phenolic derivatives or degradation products, which may be absorbed and exert functions initially
considered to be due to the parent compounds. ACNs and their metabolites could have a high potential
to reduce inflammatory markers, such as cytokines, intercellular adhesion molecule (ICAM-1), vascular
cell adhesion molecule (VCAM-1) and E-selectin on the surface of TNF-α-activated endothelial cells in
this context; gut microbiota may play an important role in generating possible fermentation products
affecting vascular health.
Considering that ACNs and colonic catabolites of polyphenols may have different bioactivity,
the aim of the present study was to investigate the microorganism-ACN interactions involved in the
colonic metabolism of ACNs used in an in vitro co-culture model with epithelial cells mimicking
the intestinal layer and endothelial cells mimicking the vascular side. Therefore, after batch culture
fermentation of an ACN-rich grape/berry extract with different human commensals (Escherichia coli,
Enterococcus faecalis and Hafnia alvei), changes in (1) the growth responses of these commensals;
(2) ACN fermentation, as well as (3) the protective effects of fermented ACNs on low- and high-grade
inflammation events in the in vitro epithelial-endothelial co-culture model were monitored.
2. Materials and Methods
2.1. Materials
TNF-α was obtained from R & D (Heidelberg, Germany) and Calcein-AM from Invitrogen
(Heidelberg, Germany). Ethanol, methanol and formic acid were supplied by Merck KGaA (Darmstadt,
Germany). Cell culture media (MCDB131) and supplements (EGF, ECGF) for human umbilical vein
endothelial cells (HUVECs) were obtained from Promocell (Heidelberg, Germany) and those for
Caco-2 cells (Dulbecco’s Eagle’s Minimum Essential Medium (DMEM)) from Invitrogen (Heidelberg,
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Germany). Fetal calf serum (FCS) was supplied by Biochrome (Berlin, Germany), lysogeny broth (LB)
for the culture of Gram-negative microorganisms by Life Technologies GmbH (Darmstadt, Germany)
and tryptic soy broth (TSB) for the culture of Gram-positives by Merck KGaA (Darmstadt, Germany).
Human plasma fibronectin was obtained from Invitrogen (Heidelberg, Germany). All chemicals were
of analytical grade and cell culture tested.
2.2. Methods
2.2.1. Anthocyanin-Rich Grape/Bilberry Extract
The ACN-rich grape/berry extract made of red grapes (80/20 mixture of the grape varieties
Dakapo and Accent) and bilberries (Vaccinium myrtillus) was produced at Geisenheim University
(Section of Wine Analysis and Beverage Technology). Briefly, grapes were extracted in a press, and
the resulting juice was separated, blended with bilberry juice from concentrate and pasteurized. The
grape-bilberry juice was loaded onto a pilot glass column (Kronlab/Schott, 200 ˆ 750 mm) filled
with 16 L of adsorber resin (Resindion/Mitsubishi, Mailand, Italy). Water-soluble juice constituents
like sugars, organic acids and minerals were washed out with two bed volumes of distilled water.
The first eluate was slightly colored due to low ACN levels. The ACNs and colorless polyphenols
were eluted with two bed volumes of 96% ethanol. The ethanolic fraction was concentrated by
a rotary evaporator and lyophilized. ACNs were analyzed by HPLC-PDA/ESI-MS (high-performance
liquid chromatography/photo diode array detection/electrospray ionization mass spectrometry); their
content is given in Table 1.
Table 1. Anthocyanins (ACNs) in grape/berry extract. The extract was analyzed by HPLC-PDA/ESI-
MS; ACN concentrations are given as mg/L and µmol/L (mean ˘ SD, n = 3).
Anthocyanins (mg/L) (µmol/L)
malvidin-3-glucoside 419.0 ˘ 1.5 849.1 ˘ 3.0
malvidin-3-(6”-p-coumaryl)-glucoside 102.9 ˘ 0.6 160.9 ˘ 0.9
malvidin-3-(6”-O-acetyl)-glucoside 87.8 ˘ 0.5 164.0 ˘ 0.9
malvidin-3-arabinoside 5.4 ˘ 0.2 11.7 ˘ 0.4
malvidin-3,5-diglucoside 5.3 ˘ 0.1 8.2 ˘ 0.2
Σ malvidin 615.1 ˘ 2.8 1185.7 ˘ 5.2
peonidin-3-glucoside 248.9 ˘ 0.6 537.1 ˘ 1.3
peonidin-3-(6”-O-acetyl)-glucoside 31.2 ˘ 0 61.7 ˘ 0.0
peonidin-3,5-diglucoside 7.4 ˘ 0.8 11.8 ˘ 1.3
Σ peonidin 287.5 ˘ 1.4 610.6 ˘ 2.6
delphinidin-3-glucoside 96.4 ˘ 1.3 207.1 ˘ 2.8
delphinidin-3-arabinoside 14.2 ˘ 1 32.6 ˘ 2.3
delphinidin-3-galactoside 15.5 ˘ 0.2 33.3 ˘ 0.4
delphinidin-3-(6”-O-acetyl)-glucoside 9.1 ˘ 0.3 17.9 ˘ 0.6
Σ delphinidin 135.2 ˘ 2 290.9 ˘ 6.1
petunidin-3-glucoside 103.4 ˘ 0,8 215.7 ˘ 1.7
petunidin-3-(6”-p-coumaryl)-glucoside 29.9 ˘ 0.2 47.8 ˘ 0.3
petunidin-3-(6”-O-acetyl)-glucoside 17.0 ˘ 0.1 32.6 ˘ 0.2
Σ petunidin 150.3 ˘ 1.1 296.1 ˘ 2.2
cyanidin-3-glucoside 62.9 ˘ 0.5 140.0 ˘ 1.1
cyanidin-3-galactoside 21.8 ˘ 0.6 48.5 ˘ 1.3
cyanidin-3-arabinoside 17.4 ˘ 0 41.5 ˘ 0.0
Σ cyanidin 102 ˘ 1.1 230.0 ˘ 2.4
Sum of ACNs 1295.5 ˘ 9.3 2621.5 ˘ 18.7
2.2.2. Determination of ACNs and Metabolites in In Vitro Samples Using UPLC and MS Measurement
Ultra-performance liquid chromatography (UPLC) separation was performed using an UltiMate
3000 RSLC (Rapid Separation LC) system (Dionex, Idstein, Germany) equipped with a pump
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(HPG 3200 RS), an autosampler (WPS-3000 TRS) and a 100 mm ˆ 2.1 mm ID, 2.6-µm particle
size, Kinetex reversed phase (C18) column (Phenomenex, Aschaffenburg, Germany). Mobile phases
consisted of 0.7% v:v formic acid in water (Solvent A) and methanol (Solvent B). The solvent gradient
was 2% B at 0–0.5 min, 7% B at 1 min, 15% B at 5 min, 40% B at 10 min, 70% B at 13–16 min at a flow
rate of 400 µL/min (p(max) = 550 bar). The injection volume was 5 µL. The UPLC system was coupled
to an Exactive™ Orbitrap mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) by an
electrospray ion source. Capillary temperature was set to 350 ˝C; spray voltage in positive ion mode
was 4.4 kV and in negative ion mode 3.5 kV. Measurements were performed by continuously switching
between positive and negative ion mode. Mass spectra were acquired in the range of m/z = 200–850
for positive ion mode and m/z = 100–850 for negative ion mode.
2.2.3. Commensal Microorganisms and Culture Conditions
The influence of the ACN-rich grape/berry extract on the growth behavior of commensal
microorganisms (MO) was first screened for 35 bacterial species belonging to the genera Bacillus,
Bacteroides, Branhamella, Citrobacter, Enterobacter, Enterococcus, Escherichia, Hafnia, Klebsiella, Lactobacillus,
Lactococcus, Listeria, Morganella, Pediococcus, Proteus, Providencia, Serratia, Salmonella, Shigella,
Staphylococcus and Yersinia. The supplementation of the growth media with ACN-rich grape/berry
extract revealed three phenotypes: (I) growth restriction; (II) growth promotion; and (III) no impact
on growth. As the trait “pathogenic” or “non-pathogenic” was not associated with the observed
phenotype, we performed the experiments with non-pathogenic bacteria representing each of the three
phenotypes, i.e., with the Gram-positive Enterococcus faecalis (E. faecalis; Symbioflor 1; Phenotype I), as
well as with the Gram-negative Escherichia coli (E. coli; K12; Phenotype II) and Hafnia alvei (H. alvei;
wild-type; Phenotype III). H. alvei and E. coli were cultured with gentle shaking in a conical flask
in lysogeny broth (LB; Life Technologies GmbH, Darmstadt, Germany) under aerobic conditions
at 37 ˝C, whereas E. faecalis was cultured in tryptic soy broth (TSB; Merck, Darmstadt, Germany)
under the same conditions. Briefly, a pure colony was used to inoculate 10 mL of broth in a 100-mL
flask and incubated under vigorous shaking at 37 ˝C overnight. The overnight cultures were diluted
1:50 in the medium containing the ACN-rich grape/berry extract (50 µmol/L malvidin-3-glucoside
(Mal-3-glc)-equivalents) or in medium without ACNs (control). The growth of these commensal MOs
was assayed in time-dependent experiments by determining the optical density (OD) at 600 nm using
a UV-VIS-spectrophotometer (Shimadzu UV 1001). Three different time points were examined: the
lag-phase (1); the logarithmic phase (log-phase) (2); and the stationary phase (stat-phase) (3). After
centrifugation of 1-mL aliquots in a Biofuge-15 centrifuge (Heraeus, Hanau, Germany) at 10,000 rpm
for 10 min, the MO-free supernatant was filtered through a 0.2-µm polyethersulfone membrane (PES)
Whatman filter (Sigma-Aldrich, Munich, Germany), acidified with 0.1% formic acid/H2O to pH 2.0
in order to reduce storage degradation. The aliquots were stored at ´80 ˝C until further analysis
(quantification of ACNs and degradation products (see “UPLC and MS Measurement for In Vitro
Samples”) and the application to the in vitro system (see “Establishment of an Epithelial-Endothelial
Co-Culture System”).
2.2.4. Establishment of an in Vitro Epithelial-Endothelial Co-Culture System
In order to investigate the anti-inflammatory effects of MO-fermented ACNs and their metabolites
on endothelial cells, we developed an in vitro co-culture system with human intestinal epithelial cells
(Caco-2) and human umbilical vein endothelial cells (HUVECs), as previously published [27]. Caco-2
cells were grown on semipermeable filters over 21 days in order to differentiate and develop a small
intestinal cell-like phenotype. After differentiation, transwell filters were inserted onto a 24-well plate,
where HUVECs had been cultured on the bottom of the cavity. After equilibration, epithelial cells in
the upper compartment were exposed to the supernatant of the MO batch culture collected at lag- (1),
log- (2) or stat-phase (3). Two hundred forty minutes later, inserts were removed, and HUVECs were
used immediately (short-term incubation) or further incubated for 20 h (long-term incubation). To
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mimic LGI or high-grade inflammation (HGI), HUVECs were incubated for 3 h with 1 or 10 ng/mL
TNF-α, respectively. After TNF-α stimulation, we determined: (1) leucocyte adhesion to HUVECs;
(2) the expression of cell adhesion molecules; (3) the expression of NF-κB (RelA); and (4) the expression
of the cytokines IL-6 and IL-8 (mRNA and protein expression).
The model for investigating MO-fermented ACNs and their metabolites in the established
co-culture system is shown in Figure 1.
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Figure 1. Determination of the anti-inflammatory effects of microorganism (MO)-fermented ACNs and
their metabolites from lag- (1), log- (2) and stat-phase (3) in an in vitro epithelial-endothelial co-culture
cell system by using, e.g., E. coli supernatants.
2.2.5. Epithelial and Endothelial Cells for the Co-Culture System
Intestinal Epithelial Cells (Caco-2 Cells)
The human colon adenocarcinoma cell line Caco-2 (HTB37™) was obtained from ATCC
(ATCC/LGC standard GmbH, Wesel, Germany). The cells were routinely grown in 75 cm2 culture
flasks using Dulbecco’s Eagle’s Minimum Essential Medium (DMEM) at pH 7.4 with 1% non-essential
amino acids (NEAA) and 10% fetal calf serum (FCS). Cells were maintained in a humidified atmosphere
of 5% CO2 in air at 37 ˝C. Stock passages were subcultured every four days before reaching
80%–90% confluence. For incubation studies, pre-confluent cells were trypsinized with a 0.25%
(w/v) trypsin/0.53 mM EDTA solution, and 104 cells were seeded onto a 24-well transwell-insert with
a polycarbonate membrane (0.4-µm pore size, Becton-Dickinson, Heidelberg, Germany) and placed
in a 24-well cavity. Cells were allowed to grow to confluence (2 days) and thereafter to differentiate
into absorptive enterocytes in 21 days. The culture medium was changed every 2–3 days at the apical
(0.5 mL) and basolateral side (1.5 mL). Alkaline phosphatase activities were measured to confirm
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differentiation of Caco-2 cells to an intact intestinal monolayer [27]. Furthermore, for all transport
experiments, the transepithelial electrical resistance (TEER), a measure of the integrity of polarized
epithelial cell monolayers, was determined before and after the experiments by using a Millicell® ERS
volt-ohmmeter (Millipore Corporation, Bedford, MA, USA). A TEER value ě 550 Ω per cm2 was used
as an indicator for an intact epithelial layer [27].
Endothelial Cells
HUVECs were obtained from Promocell (Heidelberg, Germany) from pooled donors (up to
four different umbilical cords). Endothelial cells were cultured on 75-cm2 flasks at 37 ˝C, 5% CO2
in MCDB131 (Promocell) supplemented with 10% FCS (Biochrom, Berlin, Germany), 1 µg/mL EGF
and 30 µg/mL ECGF (Promocell). After reaching 80% confluence, cells were passaged at a 1:3 split
ratio with trypsin/EDTA (0.05%/0.01%) solution and were used until Passages 2–4. Trypsinized cells
(1 ˆ 105) were seeded on fibronectin-coated (Biochrom, Berlin, Germany) 24-well plates and allowed
to grow until confluence (2 days) to be further used in co-culture experiments.
Incubation Studies with MO-Fermented ACNs in the Co-Culture System
For incubation studies, the medium from differentiated Caco-2 cells on transwell filters was
decanted, and inserts with cells were carefully washed with the medium at 37 ˝C and transferred to a
24-well plate. Apical and basolateral compartments were filled for equilibration (30 min, 37 ˝C) with
0.5 and 1.5 mL medium, respectively. After equilibration, supernatants from batch cultures (with and
without ACNs) from the lag-, log- and stat-phase were added to the apical compartment with Caco-2
cells to allow transport of metabolites to the basolateral compartment where HUVECs were attached
(compare Figure 1).
In a first set of experiments, media of apical and basolateral compartments were taken after 0, 120
and 240 min, mixed with 1% formic acid/H2O to prevent further degradation and stored immediately
at ´80 ˝C until further analysis. Apical compartments were analyzed without solid-phase extraction
(SPE) with UHPLC-MS/MS, and basolateral compartments were subjected to solid-phase extraction
(SPE) cartridges on octadecylsilane (HLB; Waters Corp., Milford, MA, USA) following the method
described previously [28].
In a second set of experiments, cell viability was investigated. To exclude the cytotoxic effects of
the incubation medium, cell counts and cell viability were determined by using the Guava® ViaCount™
assay on the Guava EasyCyte flow cytometer (Millipore Merck, Billerica, MA, USA). We measured cell
viability before (0 h) and after incubation of HUVECs with cell media from the basal compartment
(4 h) to ensure the viability of HUVECs during co-cultivation with intestinal cells. In all cases, viability
remained between 85% and 90%. Furthermore, after each incubation experiment (short-term and
long-term incubation and TNF-α-stimulation), HUVEC cell viability was tested concomitantly with the
expression of cell adhesion molecules (see “Analysis of Cell Adhesion Molecules by FACS Analysis”)
to ensure that there was no cytotoxic effect by possible metabolites from test substances [27].
In a third set of experiments, transwell inserts with Caco-2 cells were removed after 240 min
of incubation. HUVECs were either used immediately or cultured for additional 20 h in order to
evaluate a short or long time effect of ACNs and their possible metabolites. Thereafter, HUVECs were
incubated with 1 ng/mL TNF-α for 3 h to mimic an LGI or with 10 ng/mL TNF-α to mimic an HGI.
After endothelial activation with TNF-α, anti-inflammatory effects were measured.
2.2.6. Anti-Inflammatory Effects
Leukocyte Cell Adhesion Assay
To evaluate leukocyte adhesion to HUVECs, we isolated leukocytes as previously described [29].
Leukocytes (0.5 ˆ 106 cells/mL) were incubated for 15 min with 1 µmol/L Calcein-AM (Invitrogen,
Heidelberg, Germany). After intracellular hydrolysis to calcein, leukocytes were washed twice with
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pre-warmed GIBCO® Hank’s Balanced Salt Solution (HBSS) to remove extracellular Calcein-AM
solution. Centrifuged cells (5 min, 1500ˆ g) were resuspended in 600 µL HBSS and immediately used
for adhesion studies. Therefore, medium from TNF-α activated HUVECs of the co-culture system was
removed and replaced by 600 µL HBSS containing calcein-dyed leukocytes (0.5 ˆ 106 cells/mL). After
a 5-min incubation under shaking (150 rpm/min, 37 ˝C), the leukocyte suspension was aspirated, and
the wells were washed twice by HBSS to eliminate leukocytes only loosely attached to endothelial
cells. Firm adhesion was recorded by measuring the fluorescence of calcein-dyed cells at 538 nm after
excitation at 485 nm using a fluorescence multiwell-plate reader (Fluoroskan Ascent, Labsystems,
Bornheim-Hersel, Germany). A calibration curve using 1 ˆ 103–5 ˆ 105 cells was established to
quantify cell adhesion. In each set of experiments samples without ACNs in the growth medium (lag-,
log- and stat-phase) served as their own controls. The effect of fermented ACNs on leukocyte adhesion
to TNF-α stimulated HUVECs (n = 3, each done in duplicate) was calculated as percent of the adhesion
to simulated HUVECs without ACNs in the media (positive control, which was set to 100%).
Analysis of mRNA Expression of Cell Adhesion Molecules and Cytokines by Real-Time PCR
After the incubation experiments described above, mRNA from HUVECs was isolated using
the Dynabeads mRNA DIRECT™ kit (Life Technologies, Darmstadt, Germany) according to the
manufacturer’s instructions. cDNA synthesis was carried out in a reaction volume of 20 µL containing
500 ng RNA, 50 mM Tris-HCl (pH 8.3), 75 mM KCL, 3 mM MgCl2, 10 mM dithiothreitol, 100 ng
oligodeoxythymidine 15 primer, 500 µM of each deoxynucleotide triphosphate (dATP, dGTP, dCTP
and dTTP), 10 U ribonuclease inhibitor and 200 U MulV (Moloney murine leukemia virus reverse
transcriptase); all reagents were obtained from Invitrogen. The samples were incubated at 37 ˝C
for 60 min, followed by an incubation at 95 ˝C for 15 min. mRNA expression of target genes was
measured using the 7500 Real-Time PCR System (Applied Biosystems, Darmstadt, Germany). The
gene-specific primers and probes used in this study (Table 2) were designed using the sequences
accessible in the NCBI Reference Sequence and the Primer Express software 3.0 (Applied Biosystems,
Foster City, CA, USA). All probes were labeled with the fluorescent dyes 5-FAM (6-carboxy-fluorescein)
as the reporter and 3-TAMRA (6-carboxy-tetramethyl-rhodamine) as the quencher. Primers and probes
were purchased from Sigma (Deisenhofen, Germany). A total reaction volume of 25 µL contained
1ˆ reaction buffer with 250 nmol of each primer, 150 nmol probe and 1 µL cDNA. The PCR running
conditions were: 10 min of initial denaturation at 95 ˝C, followed by 45 cycles of 30 s at 95 ˝C, 30 s at
58 ˝C for annealing, 30 s at 60 ˝C and 15 s at 75 ˝C. Samples were run in triplicate. Real-time RT-PCR
results are shown as the relative expression level of normalized samples (∆ cycle threshold (Ct)) in
relation to the expression of the calibrator sample (2´∆∆Ct). The Ct value refers to the cycle number at
which the amplification curve crosses the threshold line; ∆Ct is calculated by subtracting the Ct value
of the corresponding housekeeper gene GAPDH (endogenous reference control) from the specific Ct
value of the target gene, and ∆∆Ct is obtained by subtracting ∆Ct of each experimental sample by
the ∆Ct of the calibrator. In each set of experiments, samples without ACNs in the growth medium
(lag-, log- and stat-phase) served as their own controls. Relative expression levels (n = 3, each done
in duplicate) in TNF-α-stimulated HUVECs without ACNs in the media were used as the positive
control; the effects of ACNs on the expression levels of cell adhesion molecules and cytokines were
then calculated in relation to the positive control, which was set to 100%. The inhibition of expression
(samples with ACNs in growth medium) was compared in relation to the positive control.
Analysis of Cell Adhesion Molecules by Flow Cytometry
After stimulation of HUVECs with TNF-α for 3 h, cells were washed twice with cold PBS,
removed by careful trypsinization and pelleted (150ˆ g, 5 min). Following two washes with FACS
buffer (Ca/Mg-free PBS with 0.5% FCS), cells were incubated with FS (fluorescein)-conjugated
mouse monoclonal anti-human ICAM-1 (CD54) and anti-human E-selectin (CD62E), as well as with
PE (phycoerythrin)-conjugated mouse monoclonal anti-human VCAM-1 (CD106) (R&D Systems,
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Heidelberg, Germany) for 1 h at 4 ˝C. Isotype controls for PE (mouse IgG2a isotype control PE)
and FS (mouse IgG1 isotype control FS) were used as negative controls. For each test, 10 µL PE- or
FS-conjugated antibodies per well were incubated and analyzed by flow cytometry in a cytofluorometer
(Millipore GmbH, Schwalbach, Germany). Quantification of adhesion molecule expression was
obtained using CytoSoft Version 4.2.1 software (Millipore, Darmstadt, Germany) by comparing mean
fluorescence intensities (MFI). In each set of experiments samples without ACNs in the growth medium
(lag-, log- and stat-phase) served as their own controls. MFI of TNF-α stimulated HUVECs without
fermented ACNs in the media was set to 100% and used as the positive control; the effect of ACNs on
the expression of cell adhesion molecules was calculated in relation to the positive control (n = 3, each
done in duplicate).
Table 2. Sequence of primers and probes used for real-time PCR.
Gene GenBank Accession No. Primer and TaqMan Probe Sequence
E-selectin M30640
Forward primer: 51-CCCGTGTTTGGCACTGTGT-31
Reverse primer: 51-GCCATTGAGCGTCCATCCT-31
TaqMan probe: 51-Fam-CAAGTTCGCCTGTCCTG-Tamra-31
VCAM-1 M60335
Forward primer: 51-GGGAAGCCGATCACAGTCAA-31
Reverse primer: 51-ATGAGATGATCTCCTTTCAGTAAGTCTATC-31
TaqMan probe: 51-Fam-TCAGTTGCTGATGTATACCCATTTGA- CAGGC-Tamra-31
ICAM-1 NM_000201
Forward primer: 51-GCAGACAGTGACCATCTACAGCTT-31
Reverse primer: 51-CTTCTGAGACCTCTGGCTTCGT-31
TaqMan probe: 51-Fam-CCGGCGCCCAACGTGATTCT-Tamra-31
IL-6 M54894
Forward primer: 51-GGTACATCCTCGACGGCATCT-31
Reverse primer: 51-GTGCCTCTTTGCTGCTTTCAC-31
TaqMan probe: 51-Fam-TGTTACTCTTGTTACATGTCTCCTTTCTCAGGGCT-Tamra-31
IL-8 M28130
Forward primer: 51-AGCTGGCCGTGGCTCTCT -31
Reverse primer: 51-TTTAGCACTCCTTGGCAAAACTG -31
TaqMan probe: 51-Fam-CAGCCTTCCTGATTTCTGCAGC-TCTGTG-Tamra-31
NF-κB (RelA) NM_62399
Forward primer: 51-AGCACAGATACCACCAAGACCC-31
Reverse primer: 51-CCAGGGAGATGCGCACTG-31
TaqMan probe: 51-Fam-CATCAAGATCAATGGCTACACGGACCAGG-Tamra-3
β-actin NM_002046
Forward primer: 51-CCACATCGCTCAGACACCAT-31
Reverse primer: 51-GTGACCAGGCGCCCAATA-31
TaqMan probe: 51-Fam-AGGTCGGAGTCAACGGATTTGG-Tamra-31
Cytokine Determination
IL-6 and IL-8 concentrations present in the supernatants of TNF-α-stimulated HUVECs were
measured using RayBio immunoassays (BioCat GmbH, Heidelberg, Germany) and the Digiscan Reader
(Asys Hitech GmbH, Eugendorf, Austria) according to the manufacturer’s instructions. IL-6 and IL-8
protein expression was calculated using Microwin software Version 2.15 (Asys Hitech, Eugendorf,
Austria). In each set of experiments, samples without ACNs in the growth medium (lag-, log- and
stat-phase) served as their own controls. Il-6 and IL-8 protein concentrations of TNF-α-stimulated cells
were set to 100% and used as the positive control, and the inhibition of protein expression (samples
with ACNs in growth medium) was compared to the positive control (n = 3, each done in duplicate).
2.2.7. Statistical Analysis
We have investigated each effect in three independent experiments, and each experiment
was conducted at least with duplicates. Results are presented as the mean values ˘ SEM,
the mean values ˘ SD or relative to controls (%) as indicated (n = 3). Data were statistically
evaluated using GraphPad Prism software Version 6.0.7 (La Jolla, CA, USA); differences between
and within experimental groups were analyzed using the two-tailed unpaired Student’s t-test and
ANOVA, respectively. Differences were accepted as statistically significant at a p-value < 0.001 ***,
< 0.01 ** or < 0.05 *.
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3. Results
3.1. Microbial Growth Response and ACN Fermentation
The ACN-rich extract of grapes and bilberries was tested for growth properties and MO activities
against Gram-positive E. faecalis and Gram-negative E. coli and H. alvei. The selected microorganisms
are commensals inhabiting the gastrointestinal tract of humans [30]. As shown in Figure 2, the three
MO commensals exhibited different growth responses. Growth of H. alvei was not affected by ACNs
in the media (Figure 2a), whereas that of E. coli was significantly enhanced in the presence of ACNs in
the growth medium (Figure 2b). In E. faecalis, however, ACNs caused a significant growth inhibition
(Figure 2c). For both Gram-negatives, H. alvei and E. coli, the lag-phases were very short, indicating
a quick adaptation to the different growth conditions, whereas E. faecalis required significantly more
time to adapt (Figure 2).
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Figure 2. MO growth kinetics of H. alvei (a) E. coli (b) and E. faecalis (c) with or without ACNs in culture
media. MO growth media were supplement d with 50 µmol/L malvidin-3-glucoside (Mal-3-glc)
equivalents of an ACN-rich grape/b rry extract or remained non-supple e t . The growth of
the MOs was monitored spectrophotometrical y ( 600 ) and as plo ted over time (min). At
different time points (lag-phase (1), log-phase (2) and stat-ph se (3)), MO suspensions with and without
ACNs were taken and ACNs i the culture media of H. alvei, E. coli and . faec lis were determin d
as escribed in th Mat rials and M thods ( –f). Values are given as the me ns ˘ SEM (n = 3, each
done in duplicate). Differences between gro th kinetics with and without ACNs, as well between
ACN fermentation and the i itial ACN concentration in the growth media ere significant at * p < 0.05,
** p < 0.01 and *** p < 0.005 and #* p < 0.05, #** p 0.01 and #*** p < 0.005, respectively.
In order to evaluate whether ACNs were utilized by the MOs, concentrations of the main ACNs
were determined in the lag-, log- and stat-phase of growth responses (Figure 2d–f). In contrast to
H. alvei and E. faecalis, ACNs and their major components, malvidin-3-glucoside (Mal-3-glc) and
peonidin-3-glucoside (Peo-3-glc), were rapidly fermented by E. coli, i.e., after 180 min of cultivation, no
ACNs were detected in the growth media. In the case of H. alvei and E. faecalis, the decrease of ACNs in
the growth media became significant after 150 min and 300 min, respectively. Although we measured
a considerable decrease in ACN concentration, no specific degradation product could be determined.
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3.2. Apical ACN-Degradation after Incubation of Co-Cultured Caco-2 and HUVECs with Batch Cultures from
the Lag-, Log- and Stat-Phase
To evaluate whether MO-fermented ACNs were transported across the Caco-2 monolayers,
apical degradation and basolateral enrichment of ACNs or their metabolites were measured with
UHPLC-MS/MS during the 240-min incubation time of the co-culture in vitro system (Table 3).
Table 3. Degradation rates of ACNs as a function of incubation time in Caco-2 cells 1.
MO Phase Time (min) Del-3-glc Cy-3-glc Pet-3-glc Peo-3-glc Mal-3-glc
H. alvei
(1) 0 1.87 ˘ 1.00 0.48 ˘ 0.01 2.49 ˘ 0.96 8.26 ˘ 1.05 12.98 ˘ 1.25
120 0.11 ˘ 0.00 0.45 ˘ 0.03 0.48 ˘ 0.45 2.50 ˘ 0.12 * 4.41 ˘ 1.05 *
240 0.03 ˘ 0.00 0.39 ˘ 0.05 0.35 ˘ 0.10 2.32 ˘ 0.52 * 4.04 ˘ 0.95 **
(2) 0 1.36 ˘ 0.59 067 ˘ 1.15 2.07 ˘ 0.61 6.50 ˘ 0.97 11.25 ˘ 2.19
120 0.10 ˘ 0.27 0.63 ˘ 1.02 0.77 ˘ 0.35 2.96 ˘ 1.05 5.65 ˘ 1.05
240 0.05 ˘ 0.45 0.45 ˘ 0.44 0.53 ˘ 0.25 2.34 ˘ 0.16 * 4.71 ˘ 0.15 **
(3) 0 0.11 ˘ 0.09 0.45 ˘ 0.25 0.48 ˘ 0.13 2.24 ˘ 0.19 4.41 ˘ 2.56
120 0.07 ˘ 0.06 0.41 ˘ 0.35 0.61 ˘ 0.36 0.14 ˘ 0.17 4.96 ˘ 2.16
240 0.01 ˘ 0.05 0.36 ˘ 0.38 0.40 ˘ 0.46 0.20 ˘ 0.17 4.04 ˘ 1.94
E. coli
(1) 0 1.16 ˘ 0.52 0.44 ˘ 0.21 1.45 ˘ 0.32 8.69 ˘ 2.04 14.33 ˘ 3.86
120 nd 0.39 ˘ 0.16 0.31 ˘ 0.09 4.21 ˘ 1.49 7.57 ˘ 1.09
240 nd 0.34 ˘ 0.45 0.27 ˘ 0.06 3.84 ˘ 0.38 * 7.13 ˘ 0.68 *
(2) 0 0.03 ˘ 0.00 0.03 ˘ 0.00 0.06 ˘ 0.00 0.37 ˘ 0.00 0.50 ˘ 0.00
120 nd nd nd 0.32 ˘ 0.00 0.64 ˘ 0.00
240 nd nd nd 0.28 ˘ 0.00 0.53 ˘ 0.00
(3) 0 nd nd nd 0.11 ˘ 0.00 0.16 ˘ 0.00
120 nd nd nd 0.10 ˘ 0.00 0.17 ˘ 0.00
240 nd nd nd 0.10 ˘ 0.00 0.19 ˘ 0.00
E. faecalis
(1) 0 2.09 ˘ 1.05 2.09 ˘ 0.28 2.93 ˘ 1.06 10.58 ˘ 2.00 15.83 ˘ 3.55
120 0.09 ˘ 0.54 0.76 ˘ 0.25 0.82 ˘ 0.15 4.03 ˘ 1.01 7.13 ˘ 2.49
240 nd 0.63 ˘ 0.37 0.64 ˘ 0.35 3.77 ˘ 0.66 * 6.30 ˘ 1.49 **
(2) 0 0.30 ˘ 0.21 1.12 ˘ 2.25 1.04 ˘ 0.54 6.18 ˘ 2.41 9.21 ˘ 2.97
120 nd 0.45 ˘ 0.65 0.35 ˘ 0.55 2.88 ˘ 1.05 4.90 ˘ 2.49
240 nd 0.31 ˘ 0.35 0.15 ˘ 0.49 2.14 ˘ 1.00 3.84 ˘ 1.19 *
(3) 0 0.24 ˘ 0.00 0.91 ˘ 0.00 0.88 ˘ 0.00 5.22 ˘ 2.64 7.80 ˘ 5.05
120 nd 0.35 ˘ 0.00 0.26 ˘ 0.00 2.45 ˘ 2.41 4.11 ˘ 2.05
240 nd 0.23 ˘ 0.00 0.14 ˘ 0.00 1.67 ˘ 1.05 2.96 ˘ 1.05
1 MO-fermented ACN supernatants from different time points (lag-phase (1), log-phase (2) and stat-phase (3))
of H. alvei, E. coli and E. faecalis were exposed to the apical compartment of the co-culture system. Then, after
a 0-, 120- and 240-min incubation time, concentrations of ACNs and metabolites were determined in apical
and basolateral compartments as described in the Materials and Methods. Values are given as the means ˘ SD
(n = 3, each done in duplicates). Differences between ACN fermentation and the initial ACN concentration
in the growth media were significant at * p < 0.05 and ** p < 0.01. (Del-3-glc = delphidine-3-glucoside,
Cy-3-glc = cyanidine-3-glucoside, Pet-3-glc = petonidine-3-glucoside, Peo-3-glc = peonidin-3-glucoside,
Mal-3-glc = malvidine-3-glucoside>, nd = not detected).
ACN supernatants from the lag-, log- and stat-phase after MO fermentation were tested for
degradation with Caco-2 cells cultured on transwell inserts in the in vitro system (pH 7.4). As shown in
Table 3, after 240 min of incubation of ACNs with H. alvei, the losses of the major ACNs, Mal-3-glc and
Peo-3-glc, compared to their initial concentrations were significant after incubation with metabolites
generated during the lag- and log-phase of growth. Similar results after 240 min were observed for
E. faecalis (Table 3). In contrast to E. faecalis and H. alvei, only in the supernatants derived from the
lag-phase of E. coli, intact ACNs were observed, and the loss of Mal-3-glc was 50% ˘ 7% and that of
Peo-3-glc was 55% ˘ 7% after incubation for 240 min. Neither in the log-phase nor in the stat-phase
were ACNs detected in the supernatants (Table 3). Furthermore, neither ACNs nor their metabolites
could be determined in the basolateral compartment of the transwell systems (compare Figure 1).
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3.3. Inhibition of Leukocyte Adhesion to HUVEC by MO-Fermented ACNs
To investigate whether ACNs fermented by E. faecalis, E. coli and H. alvei have any
anti-inflammatory effect on the human vascular system, we examined the effects of these metabolites
from the lag-, log- and/or stat-phase on leukocyte adhesion to TNF-α-activated HUVECs in comparison
to control media without ACNs. Therefore, supernatants collected during the lag-, log- and stat-phase
from MO batch culture fermentations (with and without ACNs) were subjected to Caco-2 cells cultured
on transwell inserts.
After 240 min of incubation, the insert with Caco-2 cells was removed, and basolateral solutions
were used immediately or incubated for another 20 h with HUVECs cultured on the bottom of the
basolateral compartment (compare Figure 1). Thereafter, HUVECs were stimulated for 3 h with 1 or
10 ng/mL TNF-α.
Figure 3 shows that leukocyte adhesion to HUVECs was significantly reduced by ACNs after
fermentation by H. alvei and E. faecalis when HUVECs were pre-incubated for 24 h prior to low-grade
TNF-α stimulation (1 ng/mL; Figure 3a,c); neither short-term pre-incubation (4 h) nor high-grade
inflammatory conditions (10 ng TNF-α mL) had any effect. H. alvei and more pronounced E. faecalis
obviously generated metabolites that were able to inhibit leukocyte adhesion to TNF-α-stimulated
HUVECs. In the case of ACNs fermented by H. alvei, these effects were independent of the possible
metabolites generated in the (1) lag-, (2) log- or (3) stat-phase. Pre-incubation of metabolites generated
by E. faecalis revealed a more pronounced effect, with a greater effect induced by metabolites generated
during the lag- and log-phase compared to those from the stat-phase. Interestingly, supernatants
from E. coli-fermented ACNs did not influence leukocyte adhesion, neither after long- and short-term
incubation nor under low- or high-grade inflammatory conditions (Figure 3b).
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Figure 3. Anti‐adhesive effect of ACNs after MO‐fermentation on  leucocyte adhesion  to HUVECs 
under inflammatory conditions by (a) H. alvei; (b) E. coli and (c) E. faecalis. After incubation of Caco‐2 
cells with  fermented ACNs  from  the  lag‐  (1),  log‐  (2)  and  stat‐phase  (3),  transwell  inserts were 
removed, and the co‐cultured HUVECs were used immediately (4 h) or were further incubated in the 
basolateral compartment (20 h). Thereafter, cells were stimulated for 3 h using 1 ng/mL TNF‐α (low‐
grade  inflammation)  or  10  ng/mL  TNF‐α  (high‐grade  inflammation).  After  TNF‐α  stimulation, 
leukocyte adhesion was measured as described in the Materials and Methods section. Corresponding 
controls (maximal adhesion to HUVECs after low‐grade or high‐grade TNF‐α stimulation) were set 
to 100%. Values are given as the mean ± SD (n = 3). Differences were significant at ** p < 0.01 and *** p 
< 0.001). 
3.4. Inhibition of Adhesion Molecules Expression on HUVECs under Low‐Grade Inflammatory Conditions 
by Fermented ACNs 
Since our results from the adhesion assays (see Section 3.3) were significant for inhibiting low‐
grade inflammation and under long‐term conditions, these conditions were chosen for subsequent 
experiments. In order to investigate which adhesion molecules were responsible for the adhesion of 
leukocytes to endothelial cells, we quantified mRNA and protein levels of E‐selectin, ICAM‐1 and 
VCAM‐1. Figure 4 shows that long‐term incubation of HUVECs with the basolateral solutions with 
ACNs that had been fermented by H. alvei and E. faecalis and transported through a Caco‐2 cell layer 
resulted in a decrease of all three adhesion molecules compared to positive controls (Figure 4a,c). 
ACNs fermented by H. alvei significantly inhibited the TNF‐α‐induced protein expression with 
a greater effect on  ICAM‐1 and VCAM‐1  than on E‐selectin. A significant  inhibition of E‐selectin 
protein levels was only observed with stat‐phase‐generated ACNs, whereas ACNs generated in the 
Figure 3. Anti-adhesive effect of ACNs after O-fermentation on leucocyte adhesion to HUVECs
under inflam atory conditions by (a) H. alvei; (b) E. coli and (c) E. faecalis. After incubation of Caco-2
cells with fermented ACNs from the lag- (1), log- (2) and stat-phase (3), transwell inserts were removed,
and the co-cultured HUVECs were used immediately (4 h) or were further inc bated in the basolateral
compartment (20 h). Thereafter, cells w re stimulated for 3 h using 1 ng/mL TNF-α (low-grade
inflammation) or 10 g/mL TNF-α (high-grade inflammation). After TNF-α stimulation, leuk cyte
adhesi n was measured as desc ibed in the Materials and Metho s s ction. Corresponding controls
(maximal adhesion to HUVECs after low-grade or high-g ade TNF-α stimulation) were set to 100%.
Values are given as the mean ˘ SD (n = 3). Differences were significant at ** p < 0.01 and *** p < 0.001).
3.4. Inhibition of Adhesion Molecules Expression on HUVECs under Low-Grade Inflammatory Conditions by
Fermented ACNs
Since our results from the adhesion assays (see Section 3.3) were significant for inhibiting
low-grade inflammation and under long-term conditions, these conditions were chosen for subsequent
experiments. In order to investigate which adhesion molecules were responsible for the adhesion of
leukocytes to endothelial cells, we quantified mRNA and protein levels of E-selectin, ICAM-1 and
VCAM-1. Figure 4 shows that long-term incubation of HUVECs with the basolateral solutions with
ACNs that had been fermented by H. alvei and E. faecalis and transported through a Caco-2 cell layer
resulted in a decrease of all three adhesion molecules compared to positive controls (Figure 4a,c).
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Figure 4. Expression of the adhesion molecules E-selectin, ICAM-1 and VCAM-1 on HUVECs under
low-grade inflammation (LGI) and long-term incubation conditions fermented by (a) H. alvei; (b) E. coli
and (c) E. faecalis. After incubation of Caco-2 cells with fermented ACNs from the lag- (1), log- (2) and
stat-phase (3), transwell inserts were removed, and the co-cultured HUVECs were used after 20 h.
Thereafter, cells were stimulated for 3 h using 1 ng/mL TNF-α (LGI). After TNF-α stimulation, protein
expression (MFI, main fluorescence intensity) was measured as described in the Materials and Methods
section. Corresponding controls (maximal expression of cell adhesion molecules after LGI) were set as
100%. Values are given as the mean ˘ SD (n = 3). Differences were significant at * p < 0.05, ** p < 0.01
and *** p < 0.001.
ACNs fermented by H. alvei significantly inhibited the TNF-α-induced protein expression with
a greater effect on ICAM-1 and VCAM-1 than on E-selectin. A significant inhibition of E-selectin
protein levels was only observed with stat-phase-generated ACNs, whereas ACNs generated in the
lag- and log-phase had no effect compared to positive controls. ICAM-1 protein expression was
significantly reduced by all metabolites no matter whether they were derived from the lag-, log- or
stat-phase of growth; the greatest inhibitory effect, however, was found for VCAM-1 expression.
Similar to the effects of ACNs fermented by H. alvei, metabolites from E. faecalis influenced the
expression of all three adhesion molecules, although with a greater effect on ICAM-1 and VCAM-1
than on E-selectin expression (Figure 4c). Again, the greatest effect was observed for the inhibition of
VCAM-1 expression; ACN metabolites generated by E. coli f iled to induce any effect (Figure 4b).
C ncomit t with the reduced protein levels of the adh sion m lecules induced by ACN
metabolites generated by H. alvei and E. faecalis, mRNA expressi n was influenced in a similar way,
indicating that reduced protein expression was a result of reduc d mRNA expression levels. Again, no
effects w re observed by E. coli-generated ACN metabolites (Figure 5).
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conditions and long-ter incubation AC s fer ented by (a) H. alvei; (b) E. coli and (c) E. faecalis. After
incubation of Caco-2 cells with fer ented ACNs fro the lag- (1), log- (2) and stat-phase (3), transwell
inserts were removed, and the co-cultured HUVECs were further incubated for 20 h. Thereafter, cells
were stimulated with 1 ng/mL TNF-α for 3 h (LGI). After TNF-α stimulation, mRNA expression levels
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3.5. Inhibitory Effects of Fermented ACNs on Cytokine Expression and Secretion in HUVECs under Low-Grade
Inflammatory Conditions
To further validate the anti-inflammatory results described above, we determined the
concentrations of selected cytokines, such as IL-6 and IL-8, participating in the inflammatory process.
As shown in Figure 6, pre-treatment of TNF-α stimulated HUVECs with ACN metabolites generated
by H. alvei and E. faecalis significantly reduced mRNA and protein levels of IL-8 and, to a lesser extent,
of IL-6, whereas ACN-metabolites generated by E. coli did not have any effect.
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Fermented ACNs from the lag-, log- and stat-phase of H. alvei growth significantly reduced IL-6
and IL-8 mRNA, as w ll as protein expression c mpared to controls (Figure 6a). ACNs generated by
E. faecalis had an even stronger inhibitory effect (Figure 6c), whereas no effects were observed for E. coli
supernatants (Figure 6b).
3.6. Inhibitory Effects of Fermented ACNs on NF-κB mRNA Expression in HUVECs under Different
Low-Grade Inflammatory Conditions and Long-Term Incubation
We measured the NF-κB (RelA, Reticuloendotheliosis homolog A) mRNA expression since
NF-κB not only regulates the expression of cytokines, but also that of adhesion molecules under
inflammatory conditions. As shown in Figure 7, pre-treatment of TNF-α-stimulated HUVECs with
ACN metabolites generated from H. alvei and E. faecalis significantly reduced mRNA levels of NF-κB,
whereas E. coli-generated ACN-metabolites did not show any effect.
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Fermented ACNs from the lag- log- and stat-phase of H. alvei cultures significantly reduced NF-κB
mRNA expression (Figure 7a). Again, ACNs from E. faecalis fermentation reduced mRNA levels to an
even stronger extent (Figure 7c), whereas ACN metabolites from E. coli had no effects (Figure 7b).
4. Discussion
The link between the anti-inflammatory effects of dietary polyphenols in general and active
molecules within this diverse group of structures has not yet been clearly established. This is partly
due to open questions with regard to (1) the identification and quantification of metabolites found
in vivo, i.e., in plasma after an ACN-rich diet; and (2) the molecular mechanisms they trigger within
the target cells. The structural identity of ACNs as bioactive molecules in vivo has only scarcely been
explored due to their intense MO fermentation and intestinal metabolism in the gut. An increasing
number of reports have been published looking at methods using chemical or enzymatic synthesis
to generate phase II metabolites (such as glucuronides and methylated or sulfated conjugates) or
single known metabolites from degradation and fermentation pathways for testing their activity
in cell culture studies [31]. Recently, we reported that ACNs from a grape/bilberry extract, as
well as malvidin-3-O-glucoside (Mal-3-glc) were able to reduce parameters associated with LGI
in an epithelial-endothelial in vitro co-culture system [27]. In the present study, we investigated
the anti-inflammatory effects of ACNs in this in vitro system using MO-fermentation products of
different commensal microorganisms. We were able to show for the first time that ACN metabolites
generated from E. faecalis and H. alvei significantly inhibited leukocyte adhesion under LGI and
long-term incubation. These effects were associated with a significant downregulation of the levels
of adhesion molecules confirmed by real-time PCR and FACS analysis, as well as the inhibition of
chemokine secretion and expression in endothelial cells. These inhibitory effects partially compensated
the stimulation as LGI in endothelial cells completely (Figures 4–6). In contrast, ACNs fermented by
E. coli failed to inhibit cell adhesion and inflammation.
For the microorganisms themselves, ACNs seem to serve as substrates, however, with different
effects on the growth kinetics of the three selected commensals. The growth of E. coli for example
was enhanced in the presence of ACNs with concomitant reduction of ACNs, mainly Mal-3-glc
and peonidin-3-O-glucoside (Peo-3-glc), in the growth media. In contrast, the growth of E. faecalis
was inhibited by ACNs, and the growth of H. alvei was not affected at all. Although we observed
decreasing concentrations of ACNs, of the major ACNs Mal-3-glc and Peo-3-glc, as well as of the
minor ACNs cyanidin-, delphinidin- and petunidin-3-O-glucoside, we could not detect any ACN
metabolites in the MO growth media during the cultivation time. It has been previously described
that β-glucosidase of intestinal microbiota hydrolyzes ACNs by cleavage of the 3-O-linked glucose.
These generated aglycones were further degraded or transported across the epithelium [32]. Similar
results were reported from Sanchez-Patan et al. [22] and Hidalgo et al. [33], who identified several
metabolites after the incubation of an ACN-rich extract with fecal slurry from human volunteers.
Similar to our study, they observed a rapid decrease of Mal-3-glc and Peo-3-glc. Although they were
not able to detect any aglycones, concomitant with the decreased ACNs, they found metabolites,
such as catechol/pyrocatechol after short-term (10–30 h) and benzoic acid derivates after long-term
incubation (5–30 h). Syringic acid (4-hydroxy-3,4-dimethoxybenzoic acid) as a result of Mal-3-glc
B-ring degradation was observed only by Sanchez-Patan et al. and Hidalgo et al. after 5 h cultivation
when ACNs were degraded. Protocatechuic (4-hydroxy-3,4-dimethoxybenzoic acid) and vanillic acid
(4-hydroxy-3-methoxybenzoic acid) deriving from the B-ring degradation of cyanidin- and Peo-3-glc
were not detected. Instead, they observed a significant increase of benzoic acid as a final degradation
product [22,33].
Although most studies investigated the anti-MO effects of ACN activity [34–36], recent research
focused on ACN-related changes within the different groups of intestinal microorganisms. Thus,
Sanchez-Patan et al. analyzed various MO species after an ACN-rich diet and showed that
Bifidobacterium spp. and Lactobacillus spp. remained constant and that Clostridium histolyticum was
Nutrients 2016, 8, 411 15 of 19
inhibited. In another study with grape seed extracts, they received similar results with an enhanced
growth of Lactobacillus/Enterococcus spp. and a decrease of Clostridium histolyticum [24], which was also
observed by Hidalgo et al. [33] using Mal-3-glc or mixed ACNs. Differences between our study and
others could be attributed to the time point that the ACN-metabolites were determined, the variability
in the ACN-application (concentration and presence of major ACNs), as well as to the fermentation
model with a different set of microorganisms. In our fermentation model, we used single commensals
in order to evaluate the MO-specific contribution to ACN fermentation and the formation of possible
MO-specific metabolites.
However, in terms of the biological activity of ACNs, the MO metabolism may at least in part
be responsible for the health-promoting properties due to their anti-adhesive, anti-inflammatory
or anti-oxidative potential, e.g., the inhibition of the pro-inflammatory cytokine TNF-α and the
reduction of leukocyte adhesion to endothelial cells in particular are key mechanisms in the control
of atherogenesis. Keeping in mind that LGI is the first step in the pathogenesis of atherosclerosis,
inhibition of this step would be a great success. In this context, our results indicate that the exposure
of ACN metabolites generated by H. alvei and E. faecalis to the co-cultured intestinal-endothelial cell
culture model is associated with a significant reduction of the TNF-α-induced adhesion of leukocytes to
HUVECs under LGI conditions. We showed that TNF-α-induced leukocyte adhesion to HUVECs was
reduced following a 24-h pre-exposure to MO-derived ACN metabolites suggesting an anti-adhesive
effect of MO-specific metabolites. Furthermore, this effect could only be observed, when HUVEC cells
were stimulated with low doses of TNF-α mimicking an LGI and long-term pre-incubation (24 h),
but not after short-term incubation (4 h). Although we observed a further decrease of ACNs in the
apical compartment of the co-culture system during the incubation of intestinal cells with fermented
MO culture supernatant, no ACNs, ACN-phase-II-metabolites or other metabolites were detected at
the basolateral side, which was in accordance with previous studies [37–39]. However, it may still be
possible that unknown intermediate metabolites were generated, the effects being prominent within the
24-h pre-incubation period only. Nevertheless, anti-adhesive effects exerted by metabolites generated
by E. faecalis and H. alvei were found to be associated with changes in the expression levels of adhesion
molecules involved in these processes, such as E-selectin, ICAM-1 and VCAM-1. Interestingly, the
effect of metabolites from the stat-phase induced a greater decrease of all three cell adhesion molecules
than that of metabolites from the lag-phase, which indicates that different metabolites may have been
generated. The effect was particularly strong in the case of VCAM-1 and ICAM-1 and to a lesser
extent on E-selectin. This was demonstrated with metabolites generated by E. faecalis and to a lesser
extent with metabolites generated by H. alvei. Again, metabolites generated by E. coli did not show
any effect. The reasons why ACN metabolites generated by E. coli failed to affect LGI parameters are
not known. However, as shown in our study, ACNs seem to have been used by E. coli possibly as
a growth substrate and displayed distinct growth effects (Figure 2, Table 3). The enhanced growth
response indicates that ACNs may be suitable substrates for this strain and that the corresponding
intermediates and/or end products were different from those of E. faecalis or H. alvei along with various
vascular effects. It has recently been shown that different colonic microrganisms used Mal-3-glc or
cyanidin-3-glucoside as growth substrates in different ways and generated different metabolites [25].
The authors speculate that enzymes, such as β-glucosidases, are needed to catalyze such reactions
and, thus, could promote bacterial species. These observations are supported by Esplay et al. and
Faria et al., showing similar results with Bifidobacterium spp. and Lactobacillus spp. [40,41]. However,
the functions, mechanisms and biotransformation of ACNs to intermediates and end products remain
to be investigated in vitro or in vivo in order to get more insights into the contribution of the MO
community to vascular health effects.
In former studies, Hidalgo et al. have shown for possible breakdown products of ACNs, such
as gallic acid, that the TNF-α-induced ICAM-1 and VCAM-1 expression levels were reduced by
high concentrations of this phenolic acid (10–100 µM). It should be noted that they used TNF-α
concentrations of 10 ng/mL to mimic a chronic inflammation, a 10-times higher concentration
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compared to what we called an LGI [42]. Under these conditions, high concentrations of gallic
acid were necessary to overcome the TNF-α-induced pro-inflammatory effect in endothelial (EA.hy926,
hybridoma cell line of HUVECs and A549 (lung tumor cells)) cells. Keeping in mind that the gallic acid
concentration in plasma is considered to be low, the in vitro concentrations used were manifold higher
than that reported under physiological conditions [43]. Chau et al. showed that 100 µg/mL purple
sweet potato leaf extract and its major ACN cyanidin attenuated TNF-α-induced (2 ng/mL) VCAM-1
expression in human aortic endothelial cells (HAECs) [44]. Again, such high concentrations used in
the in vitro model do not reflect the physiological situation. However, earlier studies have shown
that the anti-adhesive action of flavonoids is mediated by their inhibitory effect on nuclear-factor
κB (NF-κB), which is in agreement with our data. In our study, the expression of NF-κB mRNA in
TNF-α-stimulated HUVECs decreased with metabolites generated by E. faecalis or H. alvei, whereas
metabolites generated by E. coli failed to downregulate NF-κB gene expression. However, inhibition of
the NF-κB signaling pathway to reduce the expression of pro-inflammatory mediators is a well-known
process, and ACNs, specifically phenolic acids, have previously been shown to influence these signaling
pathways in multiple ways [45], either by ROS-dependent p38 MAPK activation, NF-κB translocation
and NF-κB-modulated gene expression [46] or ROS independently [47]. Furthermore, Nizamutdinova
et al. have shown that ACNs not only regulate NF-κB pathways, but also differently regulate the
TNF-α-mediated expression of VCAM-1 and ICAM-1 through the modulation of the GATA and IRF-1
(IFN regulatory factor-1) binding activity via Jak/STAT-3 activation [48], but data concerning possible
metabolites have not been reported so far. The reduced NF-κB mRNA expression by metabolites
generated by E. faecalis and H. alvei correlated with the reduced expression of the cell adhesion
molecules and cytokine expression.
In our study, LGI-induced leukocyte adhesion to HUVECs was concomitant with the upregulation
of IL-6 and IL-8, chemoattractant cytokines acting as potent regulators of inflammatory atherogenesis.
Metabolites derived from the fermentation of ACNs by E. faecalis and H. alvei, however, effectively
reduced leukocyte adhesion, as well as IL-6 and IL-8 expression; metabolites from E. coli were
not effective.
5. Conclusions
Taken together, our results showed for the first time that metabolites generated by different
commensals, such as E. faecalis and H. alvei, ameliorated the inflammatory response in human
endothelial cells by reducing leukocyte adhesion to stimulated endothelial cells and by regulating
the levels of adhesion molecules and chemotactic markers, especially of IL-8 and IL-6. Under the
conditions tested (LGI and long-term incubation), these effects were significant, whereas short-term
incubation under HGI was not affected. Although it is difficult to extrapolate these data to the in vivo
situation, overall, our observations support the hypothesis that low-grade inflammation, which is
considered to be the initial step in atherogenesis, could be inhibited by ACN fermentation products.
Nevertheless, further studies are needed to identify metabolites responsible for these effects.
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